Best Biotech Stocks Right Now

Looking for biotech stocks to diversify your portfolio? These companies may be worth investing in.

AbbVie (NYSE: ABBV)

149.94 -2.485 (-1.63%)
93.35K
264.97B
149.55 - 152.39
105.56 - 175.91

AbbVie is a drug company with a strong exposure to immunology and oncology. The company’s top drug, Humira, represents close to half of the company’s current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women’s health.

Start Investing

Intercept Pharmaceuticals (NASDAQ: ICPT)

17.40 -0.47 (-2.63%)
55.12K
517.01M
17.26 - 18
11.6 - 22.36

Intercept Pharmaceuticals is a biotech company focused on developing and commercializing novel therapeutics to treat chronic liver diseases. Obeticholic acid, or OCA, is an agonist of the farnesoid X receptor. OCA was approved as Ocaliva to treat primary biliary cirrhosis in 2016 and is being developed for a variety of chronic liver diseases, including nonalcoholic steatohepatitis, or NASH.

Start Investing

AstraZeneca (NASDAQ: AZN)

63.84 0.515 (0.81%)
1.29M
197.82B
63.25 - 63.735
53.63 - 71.7

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.

Start Investing

Johnson & Johnson (NYSE: JNJ)

173.13 -2.37 (-1.35%)
1.12M
455.57B
172.8189 - 174.79
155.72 - 186.69

Johnson & Johnson is the world’s largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total sales are generated in the United States.

Start Investing

uniQure (NASDAQ: QURE)

13.43 0.01 (0.07%)
21.20K
626.48M
13.22 - 13.7
12.52 - 38.8

uniQure NV is a gene therapy company. It develops treatment and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington’s disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Start Investing

Benzinga's Proprietary Penny Stock Service is Finally Here

Get YOUR penny stock insights delivered straight to your inbox.

We’ll never share or sell your information. Privacy Policy.

Biggest Biotech Movers of the Day

Here’s the latest update on the biotech stocks with the biggest price movements on the stock exchange.

Stay up to date with the biggest premarket movers before trading sessions open on the stock market.

The data provided below is intended for educational purposes only, we have included the session dates for your reference.

Want Real Time Gainers? Start a free 14 day trial
Premarket Biotech Stocks
Symbol Last Price Change % Change Trade
SIGA 8.87 1.48 20.02% Trade
NRXP 1.58 0.26 19.69% Trade
ZEAL 13.6453 1.945 16.62% Trade
INAB 2.9501 0.41 16.14% Trade
NNVC 1.77 0.24 15.68% Trade
IMNM 3.28 0.44 15.49% Trade
INO 2.1 0.26 14.13% Trade
GOVX 0.7652 0.094 14.05% Trade
CALT 18.1918 2.202 13.77% Trade
INDP 2.84 0.34 13.59% Trade
Symbol Last Price Change % Change Trade
TNYA 5.56 -0.93 -14.33% Trade
ENTA 41.25 -4.72 -10.27% Trade
INBX 11.97 -1.23 -9.32% Trade
OCUP 1.93 -0.19 -8.97% Trade
SLRX 0.198901 -0.018 -8.35% Trade
XBIO 0.7146 -0.055 -7.2% Trade
PHGE 0.772 -0.058 -7.05% Trade
TENX 0.630101 -0.046 -6.77% Trade
EXAI 9.1583 -0.642 -6.55% Trade
ALVR 4.05 -0.26 -6.04% Trade
Market Biotech Stocks
Symbol Last Price Change % Change Trade
INDP 3 0.5 20% Trade
ZEAL 13.93 2.23 19.05% Trade
SIGA 8.76 1.37 18.53% Trade
IMMX 1.53 0.23 17.69% Trade
NRBO 0.61 0.087 16.72% Trade
CALT 18.5 2.51 15.69% Trade
SPRB 1.62 0.2 14.08% Trade
TNXP 2.18 0.26 13.54% Trade
INO 2.08 0.24 13.04% Trade
SRZN 2.9827 0.333 12.55% Trade
Symbol Last Price Change % Change Trade
ENTA 40 -5.97 -12.99% Trade
OCUP 1.86 -0.26 -12.27% Trade
SGTX 0.711 -0.087 -10.87% Trade
CNTB 0.7707 -0.082 -9.65% Trade
PSTV 0.45 -0.046 -9.33% Trade
ABOS 3.19 -0.3 -8.6% Trade
EQ 2.41 -0.215 -8.2% Trade
XBIO 0.71 -0.06 -7.8% Trade
ZSAN 1.8 -0.135 -6.98% Trade
KTRA 0.1445 -0.011 -6.78% Trade
After Hours Biotech Stocks
Symbol Last Price Change % Change Trade
FWBI 0.45 0.048 11.99% Trade
CRDF 1.44 0.15 11.62% Trade
APTO 1.15 0.1 9.52% Trade
ALDX 2.69 0.23 9.34% Trade
QLGN 0.55 0.045 8.95% Trade
SIGA 8.05 0.66 8.93% Trade
ENVB 0.214 0.015 7.75% Trade
HRTX 3.74 0.26 7.47% Trade
NRIX 10.75 0.74 7.39% Trade
CHRS 8 0.55 7.38% Trade
Symbol Last Price Change % Change Trade
ENTA 38.5 -7.47 -16.25% Trade
DRMA 0.66 -0.08 -10.83% Trade
EVAX 1.61 -0.18 -10.06% Trade
EYEN 1.85 -0.2 -9.76% Trade
TCBP 1 -0.1 -9.1% Trade
XBIO 0.7 -0.07 -9.1% Trade
CNTB 0.79 -0.063 -7.39% Trade
TCRX 3.32 -0.26 -7.27% Trade
MBRX 1.22 -0.08 -6.16% Trade
SGMO 3.57 -0.2 -5.31% Trade

Want to jump straight to the best? Most of our users prefer Interactive Brokers for stock trading.

Biotech companies are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a vaccine and boosters that can eradicate COVID-19. 

Tilt your stock portfolio toward biotech companies now and you could stand to make substantial profits in the near future. 

You can also find cost-effective stocks under $20 to trade daily on the stock exchange. 

Overview: Biotech Stocks

Biotech companies are a subsector of healthcare stocks that primarily focus on developing new drugs and treatments for medical conditions, diseases and viruses. The stock value and growth potential of a biotech firm depend on the type of diseases it treats. 

For instance, a biotech firm working on breast cancer treatments, which has nearly 300,000 new cases in the U.S. each year, might be more valuable than a company that is developing drugs for Ogilvie’s Syndrome, a rare disease that only affects 1%–3% of the population. 

Every new drug developed by biotech firms has to be submitted to the Food and Drug Association (FDA) for approval. Medical companies spend years developing a new drug but may fail to get it approved by the FDA. Some of these drugs will never hit the shelf of pharmaceuticals even after countless clinical trials. On the other hand, if a biotech company gets a new drug sanctioned by the FDA and the demand is high, the stock value can double or even triple overnight.  

Best Online Brokers for Biotech Stock

An online broker can help you trade biotech stocks with speed and precision. 

You can gain access to professional-level trading tools such as stock screens by opening an account on these platforms. Online brokers let you apply custom filters such as setting a price range to narrow down stocks under $10 within minutes. 

Explore these online brokers to get started today. 

get started securely through Webull’s website
Best For
Intermediate Traders and Investors
N/A
1 Minute Review

Webull, founded in 2017, is a mobile app-based brokerage that features commission-free stock and exchange-traded fund (ETF) trading. It’s regulated by the Securities and Exchange Commission (SEC) and the Financial Industry Regulatory Authority (FINRA).

Webull offers active traders technical indicators, economic calendars, ratings from research agencies, margin trading and short-selling. Webull’s trading platform is designed for intermediate and experienced traders, although beginning traders can also benefit.

Webull is widely considered one of the best Robinhood alternatives.

Best For
  • Active traders
  • Intermediate traders
  • Advanced traders
Pros
  • No account maintenance fees or software platform fees
  • No charges to open and maintain an account
  • Intuitive trading platform with technical and fundamental analysis tools
Cons
  • Does not support trading in mutual funds, bonds or OTC stocks
get started securely through Moomoo’s website
Best For
Active Traders
N/A
1 Minute Review

Moomoo is a commission-free mobile trading app available on Apple, Google and Windows devices. A subsidiary of Futu Holdings Ltd., it’s backed by venture capital affiliates of Matrix, Sequoia, and Tencent (NASDAQ: FUTU). Securities offered by Futu Inc., regulated by the Securities and Exchange Commission (SEC) and the Financial Industry Regulatory Authority (FINRA).

Moomoo is another great alternative for Robinhood. This is an outstanding trading platform if you want to dive deep into smart trading. It offers impressive trading tools and opportunities for both new and advanced traders, including advanced charting, pre and post-market trading, international trading, research and analysis tools, and most popular of all, free Level 2 quotes.

Get started right away by downloading Moomoo to your phone, tablet or another mobile device.

Best For
  • Cost-conscious traders
  • Active and Advanced traders
Pros
  • Over 8,000 different stocks that can be sold short
  • Access trading and quotes in pre-market (4 a.m. to 9:30 a.m. ET) and post-market hours (4 p.m. to 8 p.m. ET)
  • No minimum deposit to open an account.
Cons
  • No chat support
Get started securely through Axos Invest’s website
Best For
Sign Up Bonus
N/A
1 Minute Review

It seems like new digital investment management platforms are sprouting up left and right, and for good reason — there’s a great need for easy, straightforward investment management that doesn’t cost an arm and a leg in fees or to get started. If you’re new to investing or an old hat who wants to make the switch to a virtual manager, deciding which features you need can be confusing if not overwhelming.

If you want a no-frills financial management platform, Axos Invest (formerly WiseBanyan) takes a traditional but sophisticated approach to automated online investing.

Best For
  • Traditional investors trying out an automated investor for the first time
  • New investors that want to take a hands-off approach to portfolio management
Pros
  • Straightforward automated investing
  • Relatively low account minimum and automated investing fee
  • A solid roster of available investment account types
Cons
  • Not a stand-out from other services if you’re someone who likes all the bells and whistles with your digital financial platform
  • No direct relationship with a human financial advisor
get started securely through Interactive Broker’s website
Best For
GlobalAnalyst Product
N/A
1 Minute Review

This latest groundbreaking technology is IBKR GlobalAnalyst, a new trading tool that helps investors compare the rate of PEG or price-earnings growth valuations and provide more immediate and comprehensive financial metrics of stocks, globally.

Recognizing that stock selection can be challenging for investors to compare the valuations of domestic and international stocks, Interactive Brokers created GlobalAnalyst to offer investors a simple, yet powerful tool to easily evaluate investment opportunities around the world.

Using GlobalAnalyst, investors can search for stocks by region, country, industry, market capitalization and currency to uncover undervalued stocks worldwide. The resulting table displays the current market and financial metrics, including the PEG Ratio. The PEG Ratio is the PE ratio divided by the three-year compound earnings growth rate, and smaller PEG Ratios typically indicate undervalued companies.

Best For
  • Price earnings growth valuations
Pros
  • Easily evaluate investment opportunities
Cons
get started securely through eToro’s website
Disclosure: eToro USA LLC; Investments are subject to market risk, including the possible loss of principal.
Best For
Copy Trading
N/A
1 Minute Review

eToro is a broker that offers access to over 25 of the world’s most popular cryptocurrencies, forex and over 1600 stocks. They have a few unique education and useability tools. Traders can begin buying and selling in as little as 10 minutes.

eToro’s unique CopyTrader feature allows new investors to “copy” the buy and sell orders of professional investors, while the company’s eToro Club feature provides investors with a range of additional education tools and resources. 

Best For
  • Traders looking for an easy-to-use platform
  • Traders who want to practice their trades using a virtual account before entering the market
Pros
  • Simple platform that is easy to master
  • CopyTrader feature that allows new traders to copy the same strategies used by professionals
  • Virtual dummy account that gives you $100,000 to practice trades
Cons
  • High non-trading fees

Features to Look for in Biotech Stock

  • Earnings per share: You can determine the profitability of a company by its earnings per share (EPS). It is calculated by dividing the net income of the company by the total number of its outstanding shares.
  • Price-earnings ratio: The price-earnings ratio (P/E ratio) is calculated by dividing the current stock price by its EPS. Based on the P/E ratio, you can assess if a stock is undervalued or overvalued. The lower the P/E ratio of the stock, the better an investment it is. Generally, penny stocks under $5 have the lowest P/E ratios. 
  • Medical innovation: Biotech firms can spend years conducting clinical trials to test a new drug. Keep a constant watch on any news regarding medical breakthroughs and FDA approvals to make the most of your trade.   

Be Patient for Better Profits

Advanced medical technology has led to longer and more fulfilling lives. An investment in biotech stocks involves longer buy-and-hold periods, but if you are patient with your trades, you can strike gold when you least expect it. 

Continue reading: